EXHIBIT 10.6 LICENSE AGREEMENT BY AND BETWEEN BIOCHEMICS, INC.License Agreement • September 12th, 2003 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
ANDWarrant Agreement • December 9th, 2003 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations • New York
ARTICLE I. DEFINITIONSSecurities Purchase Agreement • August 19th, 2005 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations • New York
Exhibit 1.1 [Form of Underwriting Agreement - Subject to Additional Review] 1,200,000 SHARES OF CLASS A COMMON STOCK VASO ACTIVE PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTVaso Active Pharmaceuticals Inc • October 16th, 2003 • Pharmaceutical preparations • New York
EXHIBIT 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this "AGREEMENT"), dated as of June 16, 2003 (the "EFFECTIVE DATE"), is by and between Vaso Active Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and John J. Masiz (the...Employment Agreement • September 12th, 2003 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
EXHIBIT 10.1 EMPLOYMENT AGREEMENT -------------------- THIS EMPLOYMENT AGREEMENT (this "AGREEMENT"), dated as of August12, 2004 (the "EFFECTIVE DATE"), is by and between Vaso Active Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and...Employment Agreement • November 15th, 2004 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 17th, 2004 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 16, 2004, by and among Vaso Active Pharmaceuticals, Inc., a Delaware corporation, with headquarters located at 99 Rosewood Drive, Suite 260, Danvers, Massachusetts 01923 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (each, a “Buyer” and collectively, the “Buyers”).
Exhibit 10.9 ADVISORY AND INVESTMENT BANKING AGREEMENT This Agreement is made and entered into as of the __th day of , 2003 by and between Kashner Davidson Securities Corp. ("Kashner"), and Vaso Active Pharmaceuticals, Inc., a Delaware corporation...Advisory and Investment Banking Agreement • November 13th, 2003 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations • New York
Exhibit 1.1 [Form of Underwriting Agreement] 1,300,000 SHARES OF CLASS A COMMON STOCK VASO ACTIVE PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTVaso Active Pharmaceuticals Inc • November 13th, 2003 • Pharmaceutical preparations • New York
OHS DRAFT 8/20/03 [Form of Underwriting Agreement - Subject to Additional Review] 1,200,000 SHARES OF CLASS A COMMON STOCK VASO ACTIVE PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTVaso Active Pharmaceuticals Inc • September 12th, 2003 • Pharmaceutical preparations • New York
EXHIBIT 10.5 VASO ACTIVE PHARMACEUTICALS, INC. REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this "AGREEMENT") is entered into as of March ___, 2003, by and among (i) Vaso Active Pharmaceuticals, Inc., a Delaware corporation (the...Registration Rights Agreement • September 12th, 2003 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 17th, 2004 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 16, 2004, by and among Vaso Active Pharmaceuticals, Inc., a Delaware corporation, with headquarters located at 99 Rosewood Drive, Suite 260, Danvers, Massachusetts 01923 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SETTLEMENT AGREEMENT AND RELEASESettlement Agreement and Release • April 9th, 2004 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Settlement Agreement and Release (the “Agreement”), dated as of April 8, 2004, is entered into by and between The Riverview Group LLC (“Riverview”) and Vaso Active Pharmaceuticals, Inc. (the “Company”), a Delaware corporation (collectively the “Parties” or individually as “Party”).
MARKETING AGREEMENTMarketing Agreement • July 20th, 2004 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
THIS MARKETING AGREEMENT (“Agreement”) made as of this 9 day of March, 2004 between Vaso Active Pharmaceuticals, Inc., Inc. (“VAPH’) with a place of business at 99 Rosewood Drive, Danvers, Massachusetts, 01923, and M2G Media, Inc. and its Associates, (“M2G”) with a place of business at 6 Capstone, Irvine, CA, 92606.
As of October 12, 2005 Mr. Richard Abbe Iroquois Master Fund Ltd.Vaso Active Pharmaceuticals Inc • November 14th, 2005 • Pharmaceutical preparations
STIPULATION AND AGREEMENT OF SETTLEMENTVaso Active Pharmaceuticals Inc • April 14th, 2006 • Pharmaceutical preparations
This Stipulation and Agreement of Settlement dated as of September 21, 2005 (the “Stipulation”) is made and entered into by and among Lead Plaintiffs, Edwin Choi, Richard Cheng and Joe Huback, on behalf of the Class (as hereinafter defined) (collectively referred to hereinafter as the “Plaintiffs”), and Defendants, Vaso Active Pharmaceuticals, Inc. (“Vaso” or the “Company”), John J. Masiz (“Masiz”), Stephen G. Carter (“Carter”), Joseph Frattaroli (“Frattaroli”), Bruce A. Shear, (“Shear”), Gary Fromm (“Fromm”), Brian J. Strasnick (“Strasnick”), William P. Adams (“Adams”), Robert E. Anderson (“Anderson”) and Kashner Davidson Securities Corp. (“Kashner”) (collectively hereinafter referred to as the “Defendants”), by and through their respective counsel.
ARTICLE I INTERPRETATIONAdministrative Services Agreement • March 26th, 2004 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
STANDSTILL AGREEMENT WITH RESPECT TO CONVERSION RIGHTS, AS AMENDEDStandstill Agreement • November 14th, 2005 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations
BioChemics, Inc., a Delaware corporation (“BioChemics”), is the holder of 4,500,000 shares of Class B Common Stock, par value $0.0001 per share (the “Class B Common Stock”), of Vaso Active Pharmaceuticals, Inc., a Delaware corporation (the “Company”), which amount constitutes all outstanding shares of Class B Common Stock. As of the date of this agreement, BioChemics holds approximately a 45% economic interest in the Company.
MARKETING AND DISTRIBUTION AGREEMENTMarketing and Distribution Agreement • July 20th, 2004 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
THIS MARKETING AGREEMENT (“Agreement”) made as of this 9th day of January, 2004 between Vase Active Pharmaceuticals, Inc. (“VAPH”) with a place of business at 99 Rosewood Drive, Danvers, Massachusetts, 01923, and OrthoDistribution, Inc. (“ODI”) with a place of business at 116 Bridges Lane, North Andover, MA 0l845
As of October 12, 2005 Smithfield Fiduciary LLC c/o Highbridge Capital Management, LLCVaso Active Pharmaceuticals Inc • November 14th, 2005 • Pharmaceutical preparations
BROKERAGE AGREEMENTBrokerage Agreement • December 15th, 2005 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations
MARKETING AGREEMENTMarketing Agreement • February 13th, 2004 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations
This Marketing Agreement (the "Agreement") is entered into this 1st day of January 2004, by and between Commotion, LLC, a Colorado limited liability company ("Commotion"), with its principal place of business at 1819 Denver West Drive, Suite 260, Golden, Colorado 80401, Greg Gorman, an individual ("Gorman"), and Vaso Active Pharmaceuticals, Inc, Incorporated, a Independent Subsidiary of BioChemics, Inc., with its principal place of business at 99 Rosewood Drive, Suite 260 Danvers, MA 01923
EXHIBIT 10.7 MANUFACTURING AND DEVELOPMENT AGREEMENT THIS AGREEMENT (this "Agreement") is effective as of February 1, 2003 (the "Effective Date"), by and between VASO ACTIVE PHARMACEUTICALS, INC., a corporation organized and existing under the laws of...Manufacturing and Development Agreement • September 12th, 2003 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
BROKERAGE AGREEMENTBrokerage Agreement • April 14th, 2006 • Vaso Active Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
